Article ; Online: Stroke Associated with COVID-19 Vaccines.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
2022 Volume 31, Issue 6, Page(s) 106440
Abstract: Objectives: Development of safe and effective vaccines against coronavirus disease 2019 (COVID-19) remains the cornerstone of controlling this pandemic. However, there are increasing reports of various types of stroke including ischemic stroke, and ... ...
Abstract | Objectives: Development of safe and effective vaccines against coronavirus disease 2019 (COVID-19) remains the cornerstone of controlling this pandemic. However, there are increasing reports of various types of stroke including ischemic stroke, and hemorrhagic stroke, as well as cerebral venous sinus thrombosis (CVST) after COVID-19 vaccination. This paper aims to review reports of stroke associated with COVID-19 vaccines and provide a coherent clinical picture of this condition. Materials and methods: A literature review was performed with a focus on data from recent studies. Results: Most of such patients are women under 60 years of age and who had received ChAdOx1 nCoV-19 vaccine. Most studies reported CVST with or without secondary ischemic or hemorrhagic stroke, and some with Vaccine-induced Thrombotic Thrombocytopenia (VITT). The most common clinical symptom of CVST seen after COVID-19 vaccination was headache. The clinical course of CVST after COVID-19 vaccination may be more severe than CVST not associated with COVID vaccination. Management of CVST following COVID-19 vaccination is challenging and may differ from the standard treatment of CVST. Low molecular weight heparin is commonly used in the treatment of CVST; however, it may worsen outcomes in CVST associated with VITT. Furthermore, administration of intravenous immunoglobulin and high-dose glucocorticoids have been recommended with various success rates. Conclusion: These contradictory observations are a source of confusion in clinical decision-making and warrant further study and development of clinical guidelines. Clinicians should be aware of clinical presentation, diagnosis, and management of stroke associated with COVID-19 vaccination. |
---|---|
MeSH term(s) | COVID-19/prevention & control ; COVID-19 Vaccines/adverse effects ; ChAdOx1 nCoV-19 ; Female ; Hemorrhagic Stroke/chemically induced ; Hemorrhagic Stroke/epidemiology ; Humans ; Ischemic Stroke/chemically induced ; Ischemic Stroke/epidemiology ; Male ; SARS-CoV-2 ; Thrombocytopenia |
Chemical Substances | COVID-19 Vaccines ; ChAdOx1 nCoV-19 (B5S3K2V0G8) |
Language | English |
Publishing date | 2022-03-04 |
Publishing country | United States |
Document type | Journal Article ; Review |
ZDB-ID | 1131675-5 |
ISSN | 1532-8511 ; 1052-3057 |
ISSN (online) | 1532-8511 |
ISSN | 1052-3057 |
DOI | 10.1016/j.jstrokecerebrovasdis.2022.106440 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 3519: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.